PERSONNES
Nous faisons le lien entre les disciplines cliniques, biologiques et d'ingénierie dans les institutions suisses.
L’ÉGALITÉ DES CHANCES,
DIVERSITÉ ET INCLUSION
Le NCCR AntiResist privilégie la collaboration, l’ouverture et l’équité.
AntiResist s’attache tout particulièrement à promouvoir l’équilibre entre les sexes et à soutenir les femmes scientifiques sur le lieu de travail, dans leur parcours professionnel et lors de conférences et d’événements.
NOUS FORMONS LES FUTURES GÉNÉRATIONS DE CHERCHEURS EN INFECTIOLOGIE…
TRANSFERT DE CONNAISSANCES ET DE TECHNOLOGIES
Nous établissons des partenariats durables avec le secteur privé pour permettre l’application des découvertes de nos recherches à la pratique clinique et au développement de médicaments.
Dernières nouvelles d'AntiResist
View AllTickets now on sale for Interfinity 2025
In 2025, NCCR AntiResist is collaborating with Interfinity to bring you Surviving Superbugs – A Dance To Resist, an interdisciplinary performance...
Read moreAntiResist on Bluesky
Although AntiResist opened an account on Bluesky last year, it has been mostly inactive. From now, the AntiResist Bluesky account will be more...
Read moreNew Doctor in the House!
Huge congratulations to Dr. Hector Hernandez, who succesfully completed his PhD defence “Growth heterogeneity enables Pseudomonas aeruginosa...
Read moreAMR Conference 2025
NCCR AntiResist is delighted to be sponsoring the 9th AMR Conference again in 2025. The conference will take place on 25-26 February at the Congress...
Read moreSNSF Starting Grant for Yuping Li
The Swiss National Science Foundation (SNSF) has awarded Prof. Yuping Li from the NCCR AntiResist, at the Biozentrum of the University of Basel, one...
Read moreDr. Vishwachi Tripathi wins at Latsis Symposium
Vishwachi Tripathi, NCCR AntiResist Postdoctoral Fellow, won a Poster Prize at the Latsis Symposium on Smart Microscopy in Lausanne at the end of...
Read moreTwo new AntiResist publications
There are two new papers out from AntiResist members. Minia Antelo-Varela and others have a paper in Analytical Chemistry 2024, titled Optimizing...
Read moreNew paper from NCCR AntiResist Jenal and Hiller Labs
Protected while sleeping: How pathogens survive antibiotic treatment Drug tolerant bacteria pose a major challenge, because they can survive...
Read more